ASH23: Pharma branding, Editas’ high bar and clinical trial diversity
Bio Pharma Dive
DECEMBER 11, 2023
Editas had the tall task Monday of convincing ASH attendees its gene therapy for sickle cell disease could improve on Casgevy and Lyfgenia.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Bio Pharma Dive
DECEMBER 11, 2023
Editas had the tall task Monday of convincing ASH attendees its gene therapy for sickle cell disease could improve on Casgevy and Lyfgenia.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 14, 2024
The Subject Expert Committee (SEC), which advises the national drug regulator on matters related to approval of new drugs and medical devices and clinical trials, has recommended grant of market authorisation for Telangana-based MSN Laboratories for sleep disorder drug Pitolisant tablets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
DECEMBER 12, 2024
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. Branded drugs, developed through extensive research and clinical trials, often enjoy patent protection for a limited period.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 22, 2022
Drug manufacturers have hailed the Drugs (Eighth Amendment) Rules, 2022 mandating barcode or quick response (QR) code on the label of top 300 brands of formulations from August 1, 2023, saying that QR codes will help identify misbranded or counterfeit medicines as well as recall the products if its quality gets compromised during manufacturing.
pharmaphorum
NOVEMBER 13, 2020
Where a marketing company might own and manage a domain on behalf of a pharma brand, written proof from the brand is needed to confirm collaboration with the marketing company. Also, it is vital that all adverts and landing pages add value and are easily digestible. Case Study: UK leading emergency contraceptive pill.
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 16, 2024
Sold under the brand name Ubrelvy, ubrogepant is already used to treat migraines, but researchers in the US wanted to […]
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 15, 2024
(Abdullah Durmaz/Getty Images) In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 17, 2022
Acetaminophen, also known as paracetamol and sold widely under the brand names Tylenol and Panadol, also increases risk-taking, according to a study from 2020 […]. One of the most consumed drugs in the US – and the most commonly taken analgesic worldwide – could do a lot more than simply take the edge off your headache.
BioPharma Reporter
SEPTEMBER 3, 2020
Bluebird bio has reported end points were met in a clinical trial involving its candidate ALD cell therapy, branded as Lenti-D.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 17, 2023
The pill, called Opill – the brand name for the tablet formulation of norgestrel – is an oral contraceptive containing only progestin hormone, which helps prevent pregnancy […]
Deltaclinical
NOVEMBER 2, 2021
Along with a team of nurses and other stakeholders, the PI will conduct the trial at his/her study site. However, the sponsor will remain the monitor of the trial. The next figure shows the important stakeholders in a clinical trial. Traditionally, clinical trials have never been designed with patient-centricity in mind.
Deltaclinical
NOVEMBER 2, 2021
Along with a team of nurses and other stakeholders, the PI will conduct the trial at his/her study site. However, the sponsor will remain the monitor of the trial. The next figure shows the important stakeholders in a clinical trial. Traditionally, clinical trials have never been designed with patient-centricity in mind.
Deltaclinical
NOVEMBER 2, 2021
Along with a team of nurses and other stakeholders, the PI will conduct the trial at his/her study site. However, the sponsor will remain the monitor of the trial. The next figure shows the important stakeholders in a clinical trial. Traditionally, clinical trials have never been designed with patient-centricity in mind.
Deltaclinical
NOVEMBER 2, 2021
Along with a team of nurses and other stakeholders, the PI will conduct the trial at his/her study site. However, the sponsor will remain the monitor of the trial. The next figure shows the important stakeholders in a clinical trial. Traditionally, clinical trials have never been designed with patient-centricity in mind.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 2, 2022
Care-Keralam, the Ayush cluster in Kerala, will shortly fine-tune its strategies to build ‘Kerala Brand of Ayurveda Products’ for international marketing and to increase the quantity of exports of traditional and herbal drugs from Kerala to global markets.
WCG Clinical
JUNE 12, 2023
June 12, 2023 — WCG, one of the world’s leading providers of solutions that measurably improve the quality, efficiency, and safety of clinical research, today announces the launch of its new brand identity. In 2022, we touched 90 percent of all clinical trials globally. That’s the beauty of our new brand.”
World of DTC Marketing
OCTOBER 21, 2021
More than $170 million of this spending was for products voluntarily withdrawn by their manufacturers after clinical trials showed that they did not improve overall survival in people with various types of cancer. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5
Pharmaceutical Technology
NOVEMBER 29, 2022
According to data from the ARASENS clinical trial carried out at nearly 300 sites globally, including various NHS hospitals, subjects who received the combination therapy had a 32.5% It is branded as Nubeqa and is already offered on the NHS for patients with localised prostate cancer.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 17, 2024
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
Intouch Solutions
JANUARY 17, 2025
In a recent article published by Med Ad News , Mary Anderson, Senior VP, Managing Director and Head of MedComm at EVERSANA INTOUCH, highlighted the pivotal role medical communications (MedComm) has played in giving brands a leg up in a competitive market.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 25, 2023
The Department of Pharmaceuticals (DoP) has rejected review applications filed by the Maharashtra-based Bharat Serums and Vaccines Ltd against National Pharmaceutical Pricing Authority (NPPA) fixing the ceiling price of its infertility treatment drug brand Hucog HP, since the company did not file the petition within the prescribed time limit.
XTalks
JANUARY 29, 2021
This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster products. This means that sponsors are having to fork out for these blockbuster products in order to run their trials more often.
XTalks
MARCH 19, 2025
Over the years, Xtalks has built the industrys preeminent life science podcast, helping brands in pharma, biotech, healthcare and medical devices showcase their expertise to key decision-makers through valuable, industry-leading content. Dont miss out on this opportunity to elevate your brand and stay top-of-mind in a competitive market.
XTalks
MARCH 26, 2025
This enhances brand recognition while also attracting new clients, strategic partners and speaking opportunities that further solidify their leadership. Our Thought Leadership Checklist outlines the essential steps to position your brand as an authority in clinical research.
World of DTC Marketing
JUNE 6, 2021
The drug already exists at a lower dose as an anti-diabetic medication under the brand names Ozempic and Rybelsus made by the same pharmaceutical company, Novo Nordisk. Still study trials show Wegovy is more effective than any other weight loss management drug currently on the market.
Cloudbyz
MARCH 17, 2021
Monitoring patient safety during a clinical trial is one of the founding principles to be followed throughout the drug development life cycle. It can be defined as a collaborative relationship between sponsors, sites, researchers, and everyone involved in the clinical trial phases. Regulatory bodies governing clinical trials.
Clinical Trial Podcast
JULY 18, 2020
Have you been tasked to develop a clinical trial budget? Well, you’re in luck because I’m going to share everything you need to know about clinical trial costs. Clinical trial budgets are often put together in haste. Developing a clinical trial budget can be a confusing exercise for sponsors and CROs. Patient Grant.
Pharma Marketing Network
OCTOBER 7, 2024
In the fiercely competitive pharmaceutical industry, effective brand positioning is crucial for marketers striving to distinguish their products and services. With an ever-evolving market landscape, pharmaceutical companies must develop robust strategies to position their brands distinctively.
pharmaphorum
FEBRUARY 11, 2021
Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. He said that this can be used to shape trials to make them easier for patients, with potential benefits in terms of adherence.
pharmaphorum
SEPTEMBER 18, 2020
Roche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances of COVID-19 patients, mainly from higher risk minority ethnic backgrounds with pneumonia, progressing to mechanical ventilation or death. in the Actemra arm versus 19.3% in the placebo arm.
pharmaphorum
MARCH 15, 2022
Sanofi has agreed a deal with life sciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Sarclisa has been tipped to become a $1 billion-plus brand, but it still has a long way to go.
Pharma Marketing Network
FEBRUARY 27, 2025
Introduction In todays digital-first world, content marketing campaigns are no longer optional for pharmaceutical brands. Imagine content marketing as the heartbeat of a pharma brands digital presence. Instead of traditional promotional tactics, pharma brands can use educational content to build credibility.
XTalks
MARCH 12, 2025
This edition delved into the challenges and opportunities related to diversity in clinical trials, an essential aspect of modern clinical research that aims to ensure equitable representation and improved outcomes for all populations. DHTs : How digital tools are improving trial efficiency and accessibility.
pharmaphorum
MAY 20, 2022
Last year, the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services , an initiative that works with pharma companies on clinical trial recruitment and even hosts trial sites at certain retail locations. What made CVS decide to enter into the clinical trials space?
Pharmaceutical Technology
SEPTEMBER 14, 2022
It is marketed under the brand name Covovax in the country. The latest development was based on the totality of manufacturing, preclinical and clinical trial findings filed for assessment. This data also comprises two Phase III clinical trials: a trial in the UK and PREVENT-19 in the US and Mexico.
World of DTC Marketing
OCTOBER 11, 2021
1ne: Don’t believe that TV alone will drive brand objectives; it’s not. They’re brighter and want to understand the data behind clinical trials better. If you plan to launch a new drug with the model of heavy-up TV and a website with some programmatic ads, you’re going to fail. 7even : Beware the PR trap.
Pharma Mirror
SEPTEMBER 11, 2022
Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
Drug Patent Watch
DECEMBER 30, 2024
Types of Drug Applications The PMDA accepts three main types of drug applications: Investigational New Drug (IND) : Required for conducting clinical trials in Japan. The ANDA must demonstrate bioequivalence to the Reference Listed Drug (RLD), which is the original brand-name drug approved for marketing in Japan.
Pharma Mirror
OCTOBER 1, 2022
Clinical Edge trains and certifies visual function examiners at investigator sites conducting Phase I to IV ophthalmic clinical trials. Emmes officially rolled out the new name – OptymEdge – and branding ahead of the American Academy of Ophthalmology annual meeting, which takes place in Chicago from September 30 to October 3.
Pharmaceutical Technology
JULY 29, 2022
Eli Lilly markets olanzapine under the brand name Zyprexa. The company recently dosed the first participant in a Phase IIa placebo-controlled trial investigating INP-105 in 32 adolescents with ASD, between ages of 12 and 17. Nasal spray for acute treatment.
World of DTC Marketing
FEBRUARY 7, 2022
If they decide to continue with clinical trials, a neutral, independent third party needs to review the data. Biogen used to be known as an innovative Biotech company; now, their brand is associated with misinformation and desperation. Still, at some point, someone has to see that continuing with this product is akin to burning money.
Pharmaceutical Technology
MAY 1, 2023
The NDA is supported by the data package licensed to Ocumension by Nicox as well as the Phase III clinical trial in China. Zerviate, 0.24% was compared to emedastine difumarate ophthalmic solution, 0.05%, an antihistamine, which is marketed under undeb Emadine brand name.
BioSpace
JULY 30, 2021
The FDA has already given its go-ahead to use lumasiran to treat PH1 and lower the urinary oxalate levels in pediatric and adult patients under the brand name OXLUMO.
Pharmaceutical Technology
OCTOBER 27, 2022
To be available under the brand name Kerendia in the region, finerenone will have 10mg and 20mg tablet strengths. Health Canada approval is based on the positive data from the Phase III FIDELIO-DKD and FIGARO-DKD clinical trials of Kerendia. Both trials met the primary endpoints.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content